Shannon Walsh
(703) 838-0033, ext. 377

12 March 2016

Novo Nordisk Joins National Effort to Improve Diabetes Management with AMGA Foundation
Together 2 Goal® Aims to Improve the Lives of 1 Million People with Type 2 Diabetes

ALEXANDRIA, VA - The AMGA Foundation announced today that Novo Nordisk, Inc. awarded $1.5 million to support its national campaign, Diabetes: Together 2 Goal®. This three-year initiative will challenge leading healthcare organizations to work together to transform diabetes care for millions across the country. With this generous contribution, Novo Nordisk, Inc. will be featured as the campaign’s Presenting Corporate Collaborator.

Together 2 Goal® aims to improve care for 1 million people with Type 2 diabetes. To date, over 100 AMGA members have committed to implementing at least one of the “campaign planks”-11 evidence-based care processes-that will improve the care of people with the condition by empowering patients, improving care delivery, and leveraging information technology. Additionally, campaign participants will report data on a quarterly basis to measure progress towards this goal and utilize the campaign’s resources and tools to achieve this mark.

“We’re pleased to be a part of this significant program, as physicians are on the front lines of helping patients with this serious disease,” said Todd Hobbs, M.D., Chief Medical Officer, Novo Nordisk US. “Being a part of this AMGA Foundation initiative is important for us, as we know firsthand how devastating diabetes can be and how challenging it is to manage.”

Together 2 Goal® is the second campaign in the AMGA Foundation’s Chronic Care Challenge. In the first campaign, Measure Up/Pressure Down®, nearly 150 AMGA members worked together to improve blood pressure detection or control for more than half a million Americans. The Together 2 Goal® campaign will leverage this momentum and success to improve care for 1 million people with Type 2 diabetes.

The campaign formally launched today in Orlando, Florida during the AMGA 2016 Annual Conference. This extraordinary event featured keynote speaker Sugar Ray Leonard – Olympic athlete, world champion boxer, and diabetes advocate - who provided remarks and expressed his support for the campaign’s efforts to “knock out” this disease. Anna Windle, Ph.D., Executive Director, Medical Affairs at Novo Nordisk, Inc., provided comments and presented the campaign with a check. Representatives from hundreds of AMGA medical groups and health systems from across the country were in attendance at this premiere event.

“AMGA Foundation greatly appreciates Novo Nordisk’s dedication to improving the management of Type 2 diabetes across the nation. We welcome Novo Nordisk as the Presenting Corporate Collaborator of this crucial national campaign,” says Donald W. Fisher, Ph.D., CAE, President and Chief Executive Officer of AMGA and Secretary of the Board of AMGA Foundation. “Novo Nordisk’s support will be instrumental in furthering the aims of Together 2 Goal® and helping AMGA members make substantial improvements in care for people with Type 2 diabetes.”

Johnson & Johnson Health Care Systems, Inc. and Optum (Principal Corporate Collaborators), Merck and Sanofi (Contributing Corporate Collaborators), and DC Department of Health (Corporate Collaborator) join Novo Nordisk, Inc. as campaign corporate collaborators. Campaign partners and supporting organizations include: American Association of Clinical Endocrinologists, American Association of Diabetes Educators, American College of Physicians, American Diabetes Association, American Kidney Fund, Behavioral Diabetes Institute, DiabetesSisters, HealthyWomen, and Men’s Health Network.

For more information about the campaign, visit

About the Together 2 Goal® Campaign
The AMGA Foundation, the nonprofit arm of the AMGA, launched Together 2 Goal®, a three-year national campaign to fight the challenge of Type 2 diabetes on March 12, 2016. Together 2 Goal® includes over 100 medical groups, health systems, non-profit partners, and corporate collaborators such as the American Diabetes Association, American Association of Diabetes Educators, Novo Nordisk, Inc., Geisinger Health System, Henry Ford Health System, Intermountain Healthcare, and Ochsner Health System. The goal of the three-year campaign is to improve care for 1 million people with Type 2 diabetes by 2019.

About AMGA Foundation
The AMGA Foundation is AMGA’s nonprofit arm that enables medical groups and other organized systems of care to consistently improve health and health care. The AMGA Foundation serves as a catalyst, connector and collaborator for translating the evidence of what works best in improving health and health care in everyday practice.

About AMGA
AMGA is a 501(c)(6) trade association representing medical groups, health systems, and other organized systems of care, including some of the nation's largest, most prestigious integrated delivery systems.  AMGA is a leading voice in advocating for efficient, team-based, and accountable care. AMGA members encompass all models of organized systems of care in the healthcare industry, including: physician-owned, independent group practices, integrated delivery systems, hospital-affiliated medical groups, independent practice associations (IPAs), academic and faculty practices, accountable care organizations, and high-performing health systems. Approximately 177,000 physicians practice in AMGA member organizations, providing healthcare services for 133 million patients (approximately one in three Americans). Headquartered in Alexandria, Virginia, AMGA is the strategic partner for these organizations, providing a comprehensive package of benefits, including political advocacy, educational and networking programs, publications, benchmarking data services, and financial and operations assistance.